Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.86

-0.57

-0.29

0

Details

Expected EPS

-0.602588

Actual EPS

-0.52

Surprise EPS

0.08

Surprise Percent

+13.71%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.52 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.